tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jasper Hellweg, 83 are a BUY (91.21%), 8 are a HOLD (8.79%).
Analyst Jasper Hellweg, currently employed at ARGUS, carries an average stock price target met ratio of 82.74% that have a potential upside of 13.78% achieved within 195 days.
Jasper Hellweg’s has documented 179 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 04-Nov-2024.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 11/11/20. The price target of $88 was fulfilled within 2 days with a profit of $5.56 (6.74%) receiving and performance score of 33.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$533
$50.42 (10.45%)
$617
2 years 5 months 29 days ago
(22-Jun-2022)
2/4 (50%)
$67.25 (14.44%)
125
Buy
$550
$67.42 (13.97%)
$430
2 years 6 months 5 days ago
(16-Jun-2022)
1/2 (50%)
$95.24 (20.94%)
108
Buy
$596
$113.42 (23.50%)
$574
2 years 6 months 24 days ago
(27-May-2022)
3/5 (60%)
$76.79 (14.79%)
741
Buy
$580
$97.42 (20.19%)
$586
2 years 6 months 26 days ago
(25-May-2022)
4/6 (66.67%)
$67.58 (15.14%)
149
Buy
$545
$62.42 (12.93%)
$510
2 years 7 months 17 days ago
(04-May-2022)
7/8 (87.5%)
$36.02 (7.08%)
42
Which stock is Jasper Hellweg is most bullish on?
Which stock is Jasper Hellweg is most reserved on?
What Year was the first public recommendation made by Jasper Hellweg?
